SCM

Stonepine Capital Management Portfolio holdings

AUM $114M
1-Year Est. Return 77.6%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+77.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
-$12.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1
+$13M
2
+$5.51M
3
+$3.52M
4
CRIS icon
Curis
CRIS
+$3.41M
5
SLGL icon
Sol-Gel Technologies
SLGL
+$2.01M

Top Sells

1
+$3.59M
2
+$2.47M
3
+$2.39M
4
ELDN icon
Eledon Pharmaceuticals
ELDN
+$2.02M
5
EDSA icon
Edesa Biotech
EDSA
+$1.97M

Sector Composition

1 Healthcare 100%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OABI icon
51
OmniAb
OABI
$384M
$258K 0.23%
164,045
-536,955
XERS icon
52
Xeris Biopharma Holdings
XERS
$1.03B
$232K 0.2%
+40,030
CGEN icon
53
Compugen
CGEN
$215M
$222K 0.2%
104,300
-201,100
NMRA icon
54
Neumora Therapeutics
NMRA
$324M
$195K 0.17%
+100,000
SABS icon
55
SAB Biotherapeutics
SABS
$266M
$192K 0.17%
+50,000
SIBN icon
56
SI-BONE Inc
SIBN
$616M
$189K 0.17%
+14,964
EDSA icon
57
Edesa Biotech
EDSA
$62.2M
$157K 0.14%
30,000
-657,500
CNSP icon
58
CNS Pharmaceuticals
CNSP
$7.44M
$146K 0.13%
61,000
+12,173
PCSA icon
59
Processa Pharmaceuticals
PCSA
$7.98M
$139K 0.12%
55,000
+42,677
CABA icon
60
Cabaletta Bio
CABA
$611M
$135K 0.12%
50,000
-121,100
KLRS
61
Kalaris Therapeutics
KLRS
$112M
$118K 0.1%
+20,400
ELDN icon
62
Eledon Pharmaceuticals
ELDN
$275M
$108K 0.09%
35,000
-858,100
OVID icon
63
Ovid Therapeutics
OVID
$452M
$88.8K 0.08%
40,000
-62,367
EVAX
64
Evaxion A/S
EVAX
$31.7M
$73.3K 0.06%
19,713
-287
MNKD icon
65
MannKind Corp
MNKD
$1.07B
$39.9K 0.04%
16,300
-70,059
BCAB icon
66
BioAtla
BCAB
$6.11M
$10.5K 0.01%
+1,308
ACAD icon
67
Acadia Pharmaceuticals
ACAD
$3.56B
– –
-100,000
ARDX icon
68
Ardelyx
ARDX
$1.36B
– –
0
ARE icon
69
Alexandria Real Estate Equities
ARE
$8.98B
– –
0
CRSP icon
70
CRISPR Therapeutics
CRSP
$5.03B
– –
0
DAWN
71
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-200,000
DCTH icon
72
Delcath Systems
DCTH
$360M
– –
-27,232
ENTA icon
73
Enanta Pharmaceuticals
ENTA
$352M
– –
-100,000
FENC icon
74
Fennec Pharmaceuticals
FENC
$341M
– –
-50,000
GERN icon
75
Geron
GERN
$744M
– –
-805,800
1 2
3
4